Author: Jordan Harris

Symbio is excited to share details regarding our upcoming live webinar, “The Changing U.S. Healthcare Regulatory Landscape under President Trump”, presented by Patrick Ronan, Symbio Board Member and former FDA Chief of Staff.

Mr. Ronan will lead a discussion that explores the Trump Administration’s attempt to balance a healthcare agenda aimed at de-regulation and reducing the time and cost to develop medicines with other initiatives, such as most favored nation pricing, tariffs, tax and regulatory incentives to increase domestic manufacturing capabilities, expeditated review of therapies that align with national health priorities, and the reduction of staff and budget at key agencies such as the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). More Details

Register

Can’t make the scheduled time? Register and we will send you the recording of the complete webinar.

Our colleague, Shrutimita Pokhariyal, will represent Symbio as both a Moderator and Speaker at the upcoming 6th International Conference on Dermatology and Cosmetology (IDC2025). Shrutimita will join an inspiring lineup of global experts dedicated to advancing skin science and clinical innovation. On June 2nd, from 3:40 PM to 4:00 PM CET, she will deliver a compelling presentation titled “Design of Experiment in Injectable Trials” and reflects her deep commitment to scientific excellence and thoughtful study design.

With her deep expertise in clinical development and commitment to scientific excellence, Shrutimita’s contribution underscores Symbio’s continued dedication to innovation, quality, and thought leadership in dermatological research. We look forward to her insights sparking meaningful dialogue and collaboration at IDC2025.

Industry leaders will come together for this year’s premier event with an inspiring theme, “Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future”.

As a specialized Global CRO, Symbio is committed to advancing care in Allergy, Asthma and Immunology. With deep expertise in Dermatology, Inflammatory Disease, Aesthetics and Gastroenterology, we are excited to join global leaders advancing science and care in these critical areas.

Looking forward to connecting at EAACI and discussing how Symbio can accelerate progress with your clinical trials.

Symbio Board Member and former FDA Chief of Staff, Patrick Ronan will be a Keynote Speaker at the upcoming 16th Annual Outsourcing in Clinical Trials East Coast! “Trump Administration’s Effect on Healthcare Through the Lens of a Former Regulator”

🔹 Healthcare Themes under the Trump Administration
🔹 Update on Key Priorities and Opportunities
🔹 Short-and Long-term Effects of Staffing and Budget Cuts

Presenting: Tuesday, May 20, 12:30-1:00 pm

The Annual Dermatology Drug Development Summit is a premier industry forum that is focused on advancing next-generation immunodermatology therapies and brings together leaders and innovators from across the field. We look forward to engaging in insightful discussions, exploring groundbreaking ideas, and building meaningful collaborations with our peers.

Berlin, Germany
May 27-28, 2025

Symbio is excited to be an exhibitor at the 16th Annual Outsourcing in Clinical Trials (OCT) East conference, taking place May 20-21 at the Valley Forge Casino Resort, King of Prussia, PA. This premier event brings together industry leaders, experts, and innovators in the clinical research field to discuss the latest trends, challenges, and opportunities in outsourcing for clinical trials.

We look forward to two days of insightful panel discussions, keynote presentations, and networking sessions, all designed to facilitate knowledge sharing and strategic partnerships.

As a trusted partner in the industry, we are committed to leveraging the latest advancements to enhance trial outcomes and streamline the development process.